|
TPP2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.80779971390177E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.69599999999548E-06 |
| Normal-vs-Stage2 |
1.171830E-02 |
| Normal-vs-Stage3 |
3.604300E-02 |
| Normal-vs-Stage4 |
2.203200E-01 |
| Stage1-vs-Stage2 |
2.729800E-01 |
| Stage1-vs-Stage3 |
8.178400E-01 |
| Stage1-vs-Stage4 |
3.958200E-01 |
| Stage2-vs-Stage3 |
2.541600E-01 |
| Stage2-vs-Stage4 |
9.121800E-02 |
| Stage3-vs-Stage4 |
4.301200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.75270003960537E-09 |
| Normal-vs-AfricanAmerican |
9.631800E-04 |
| Normal-vs-Asian |
7.474800E-01 |
| Caucasian-vs-AfricanAmerican |
8.413200E-01 |
| Caucasian-vs-Asian |
8.417000E-03 |
| AfricanAmerican-vs-Asian |
2.101600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.74490005461814E-09 |
| Normal-vs-Female |
2.21199999999033E-05 |
| Male-vs-Female |
4.599400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.598400E-03 |
| Normal-vs-Extreme_Weight |
1.058930E-03 |
| Normal-vs-Obese |
3.84340000000316E-05 |
| Normal-vs-Extreme_Obese |
1.082180E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.868600E-01 |
| Normal_Weight-vs-Obese |
3.970200E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.290400E-01 |
| Extreme_Weight-vs-Obese |
1.349220E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.249400E-01 |
| Obese-vs-Extreme_Obese |
7.772200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.464260E-03 |
| Normal-vs-Age(41-60Yrs) |
2.12539985611215E-10 |
| Normal-vs-Age(61-80Yrs) |
3.83010000000183E-05 |
| Normal-vs-Age(81-100Yrs) |
6.477000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.482200E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.863200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.599210E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.675810E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.572300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.158000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.95710012032657E-10 |
| Normal-VS-Type2 PRCC |
9.818000E-03 |
| Normal-VS-KIRP CIMP |
4.580000E-01 |
| Normal-VS-Unclassified PRCC |
5.033800E-04 |
| Type1 PRCC-VS-Type2 PRCC |
5.009500E-02 |
| Type1 PRCC-VS-KIRP CIMP |
6.580600E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
2.837800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.099810E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.690500E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.762000E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.615870E-02 |
| Normal-vs-N1 |
8.215600E-03 |
| Normal-vs-N2 |
2.054600E-01 |
| N0-vs-N1 |
1.334160E-01 |
| N0-vs-N2 |
1.595580E-01 |
| N1-vs-N2 |
1.250040E-01 |
|
|
